Re: Antidepressant Pretreatment and Symptomatic Treatment in Interferon Treatment

De Bie J Robaeys G Buntinx F. Hepatitis C, interferon alpha and psychiatric co-morbidity in intravenous drug users (IVDU): Guidelines for clinical practice. Acta Gastroenterol Belg. 2005;68(1):68–80.

Morasco BJ Rifai MA Loftis JM . A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C. J Affect Disord. 2007;103:83–90.

Raison CL Woolwine BJ Demetrashvili M . Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther. 2007;25:1163–1174.

Kraus MR Schafer A Schottker K . Therapy of interferon-induced depression in chronic hepatitis C with citalopram: A randomized, double-blind, placebo-controlled study. Gut. 2008;57(4):531–536.

Kraus MR Schafer A Al-Taie O . Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepat. 2005;12:96–100.

Schaefer M Schwaiger M Garkisch AS , Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C. J Hepatol. 2005;42:793–798.

Musselman DL Lawson DH Gumnick JF . Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med. 2001;344:961–966.